Rocket Pharmaceuticals RCKT Balance Sheet (2014-2026)

NASDAQ RCKT
$2.63 +0.04 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Rocket Pharmaceuticals Quarterly Balance Sheet

Periods 50 quarters
Latest Jun 2026

Rocket Pharmaceuticals reported total assets of $423.10M and total liabilities of $54.27M for the quarter ended Jun 2026, up 0.5% year over year. This balance sheet covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
4.23M5.22M5.99M6.95M8.00M9.09M10.23M11.42M12.64M14.03M15.75M17.58M19.43M21.25M23.70M25.74M27.45M29.12M30.73M32.30M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
245.64M232.69M130.55M187.55M196.67M140.52M64.58M45.08M225.66M55.90M35.28M38.61M65.60M163.63M49.81M32.82M75.95M77.56M49.61M224.51M
Prepaid Assets
3.61M3.32M7.25M4.40M4.60M7.67M6.95M5.03M9.69M5.05M14.85M13.90M6.09M5.85M6.33M5.66M4.92M3.81M5.45M5.80M
Current Assets
425.07M392.06M353.85M325.77M311.13M364.06M338.03M312.07M446.87M378.22M345.16M292.73M241.75M378.18M324.49M277.15M227.68M192.73M149.83M289.55M
Non-Current Assets
Property, Plant & Equipment (Net)
22.09M22.30M24.35M24.85M25.61M29.01M30.59M32.99M36.53M39.17M39.34M39.55M38.51M36.79M34.56M32.52M29.77M28.17M26.66M25.10M
Long-Term Investments
43.28M28.96M34.32M
Goodwill
30.82M30.82M30.82M30.82M30.82M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M39.20M
Intangibles
25.72M25.72M25.72M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M25.15M
Goodwill & Intangibles
30.82M30.82M30.82M30.82M30.82M64.92M64.92M64.92M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M64.35M
Other Non-Current Assets
1.33M1.34M1.34M1.34M1.35M1.34M1.34M1.36M1.37M1.37M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.34M1.34M1.34M
Non-Current Assets
105.17M104.96M106.30M106.08M106.13M187.75M176.72M149.71M151.90M188.12M154.28M153.69M151.93M149.52M146.57M143.82M140.35M137.72M135.58M133.55M
Assets
530.24M497.02M460.15M431.85M417.26M551.81M514.76M461.78M598.76M566.34M499.44M446.41M393.69M527.70M471.07M420.98M368.03M330.45M285.41M423.10M
Liabilities
Current Liabilities
Accounts Payables
22.01M19.61M20.03M21.84M27.82M36.66M28.61M31.35M30.62M45.79M30.09M34.73M37.13M37.83M32.44M40.51M28.26M27.29M21.54M28.34M
Notes Payables
Payables
22.01M19.61M20.03M21.84M27.82M36.66M28.61M31.35M30.62M45.79M30.09M34.73M37.13M37.83M32.44M40.51M28.26M27.29M21.54M28.34M
Accumulated Expenses
Other Accumulated Expenses
1.11M0.72M1.64M0.65M1.88M2.27M1.79M1.26M1.85M1.77M2.75M3.06M2.77M1.62M2.94M1.71M2.67M2.33M4.22M1.35M
Current Leases
1.68M1.69M1.70M1.71M1.72M1.74M1.75M1.76M1.77M1.79M1.81M1.83M1.84M1.86M1.87M1.88M1.90M1.91M1.93M1.94M
Current Taxes
8.62M
Total Current Liabilities
24.49M22.17M22.57M24.29M30.18M39.17M31.21M34.35M33.48M48.51M32.96M37.59M39.98M40.68M35.31M43.40M31.17M30.21M24.47M31.32M
Non-Current Liabilities
Capital Leases
19.11M19.14M19.18M19.21M19.24M19.27M19.29M19.32M19.34M19.35M19.36M19.37M19.38M19.38M19.38M19.38M19.38M19.36M19.35M19.33M
Non-Current Debt
Convertible Debt
Preferred Stock Liabilities
Operating Leases
0.89M0.91M0.72M0.61M0.49M1.09M0.20M3.07M2.99M2.97M3.71M3.56M3.41M3.26M3.10M2.93M2.76M2.60M2.49M2.49M
Other Non-Current Liabilities
0.09M0.08M0.07M0.05M0.04M2.60M1.88M2.07M1.87M2.94M1.91M1.25M1.14M1.14M1.14M1.06M1.06M1.06M1.06M1.13M
Total Non-Current Liabilities
44.49M42.22M42.47M44.10M49.91M59.53M54.01M56.74M55.81M70.83M56.03M60.53M62.77M63.33M57.79M65.71M53.30M52.17M46.31M53.14M
Total Liabilities
44.58M42.30M42.53M44.16M49.95M62.12M55.88M58.81M57.68M73.77M57.94M61.78M63.92M64.47M58.93M66.77M54.36M53.23M47.37M54.27M
Shareholder's Equity
Total Debt
Common Equity
485.66M454.72M417.62M387.70M367.31M489.69M458.88M402.97M541.09M492.57M441.50M384.63M329.77M463.23M412.14M354.21M313.67M277.22M238.04M368.83M
Liabilities and Shareholders Equity
530.24M497.02M460.15M431.85M417.26M551.81M514.76M461.78M598.76M566.34M499.44M446.41M393.69M527.70M471.07M420.98M368.03M330.45M285.41M423.10M
Treasury Shares
0.00M0.00M0.00M
Retained Earnings
-447.70M-491.91M-534.90M-589.30M-647.10M-713.77M-772.11M-837.81M-899.71M-959.37M-1021.42M-1091.07M-1160.00M-1218.12M-1280.00M-1350.00M-1400.00M-1441.24M-1490.00M-1370.00M
Preferred Shares

Rocket Pharmaceuticals Balance Sheet API

Pull Rocket Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RCKT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY